Last reviewed · How we verify
NCT04837690
UEMR for Medium-sized Pedunculated Colon Polyps
trial testing UEMR in Colon Polyp in 32 participants. Status unknown.
1 September 2021
Quick facts
| Lead sponsor | Ningbo No. 1 Hospital |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 32 |
| Start date | 1 May 2021 |
| Primary completion | 1 September 2021 |
| Estimated completion | 1 October 2021 |
| Sites | 1 location across China |
Drugs / interventions tested
- UEMR
Conditions studied
- Colon Polyp — all drugs for Colon Polyp →
Sponsor
Ningbo No. 1 Hospital
Who can join
Adults 18 to 75, any sex, with Colon Polyp. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Underwater EMR (UEMR) is an emerging technique for endoscopic resection. The purpose of this research is to observ wether the UEMR for medium-sized pedunculated polyps is safe and effective.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Underwater endoscopic mucosal resection for 10-20 mm pedunculated colorectal polyps: a prospective pilot study
Gao H, Zheng S, Liu C, Yuan X, et al · · 2022 · DOI 10.21203/rs.3.rs-1961646/v1
Verify or expand the search:
- PubMed search for NCT04837690
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Colon Polyp
Currently open trials in the same condition.
- NCT06617468 — Effect of the Computer Aided Diagnosis with Explainable Artificial Intelligence for Colon Polyp on Optical Diagnosis and · NA · active not recruiting
- NCT06496958 — Water Exchange and CO2 Insufflation With Abdominal Compression Device to Reduce Manual Assistance · NA · recruiting
- NCT06073561 — Underwater Endoscopic Mucosal Resection · NA · recruiting
- NCT05990218 — Artificial Intelligence in the Detection of Right Sided Colonic Polyp in Different Operator Experience · NA · recruiting
- NCT05551052 — CRC Detection Reliable Assessment With Blood · active not recruiting
Other Ningbo No. 1 Hospital trials
Trials by the same sponsor.
- NCT07181759 — Clinical Trial of VISOR vs fURS for Upper Urinary Tract Stone · NA · not yet recruiting
- NCT07001865 — Metabolically Healthy Obesity Increases the Risks of MASLD and Hyperuricemia · enrolling by invitation
- NCT06984510 — Accelerated Biological Aging is Associated With Increased Risk of T2DM in the MASLD Population · recruiting
- NCT06905795 — Screening and Intervention of MASLD in Children · NA · active not recruiting
- NCT06987760 — Comparing Different Diameter fURSs With Similar RESDs for the Treatment of Upper Urinary Tract Stones · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04837690 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ningbo No. 1 Hospital
- Last refreshed: 8 April 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04837690.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing